Damian McNamara is a journalist for Medscape Medical News and MDedge. He worked full-time for MDedge as the Miami Bureau covering a dozen medical specialties during 2001-2012, then as a freelancer for Medscape and MDedge, before being hired on staff by Medscape in 2018. Now the two companies are one. He uses what he learned in school – Damian has a BS in chemistry and an MS in science, health and environmental reporting/journalism. He works out of a home office in Miami, with a 100-pound chocolate lab known to snore under his desk during work hours.
News
Update: U.S. regulators question AstraZeneca vaccine trial data
The NIAID statement does not say what data may have been outdated or how it may have changed the results.
News
COVID-19 virus reinfections rare; riskiest after age 65
Initial infection was associated with about 80% protection overall against getting SARS-CoV-2 again.
News
CDC data strengthen link between obesity and severe COVID
Progressively intensive management of COVID-19 might be needed for patients with more severe obesity.
News
COVID-19 vaccination linked to less mechanical ventilation
A new paper offers a “real-world” look at vaccination effectiveness, according to the authors.
News
FDA grants emergency use authorization to Johnson & Johnson COVID-19 vaccine
“The advantages of having a third vaccine, especially one that is a single shot and can be stored without special refrigeration requirements, will...
News
Janssen/J&J COVID-19 vaccine cuts transmission, new data show
"The decrease in asymptomatic transmission is very welcome news too in curbing the spread of the virus."
News
Infectious diseases ‘giant’ John Bartlett: His ‘impact will endure’
Shortly after joining Johns Hopkins in 1980, Dr. Bartlett focused on HIV/AIDS research and caring for people with HIV.
News
J&J vaccine 85% efficacious against severe COVID globally
The efficacy against severe disease provided by the Janssen/J&J vaccine held true regardless of age, race/ethnicity, absence or presence of...
Article
What we know and don’t know about virus variants and vaccines
One of the major concerns remains the ability of COVID-19 vaccines to work on new strains.
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
News
The next likely COVID-19 vaccine has its advantages
A single Ad26.COV2.S dose was associated with S-binding and neutralizing antibodies in more than 90% of the participants.
News
Early use of high-titer plasma may prevent severe COVID-19
Administering convalescent plasma that has high levels of antibodies against SARS-CoV-2 within the first 3 days of symptoms was associated with...